Rupa Joshi

1.1k total citations
36 papers, 744 citations indexed

About

Rupa Joshi is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Rupa Joshi has authored 36 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 12 papers in Pediatrics, Perinatology and Child Health and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Rupa Joshi's work include Epilepsy research and treatment (13 papers), Pharmacological Effects and Toxicity Studies (12 papers) and Drug Transport and Resistance Mechanisms (5 papers). Rupa Joshi is often cited by papers focused on Epilepsy research and treatment (13 papers), Pharmacological Effects and Toxicity Studies (12 papers) and Drug Transport and Resistance Mechanisms (5 papers). Rupa Joshi collaborates with scholars based in India, United Kingdom and United States. Rupa Joshi's co-authors include Bikash Medhi, Ajay Prakash, Sazal Patyar, BK Das, Manjari Tripathi, Amitava Chakrabarti, Niti Mittal, Amit Raj Sharma, Debasish Hota and Yogendra Kumar Gupta and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetologia and Epilepsia.

In The Last Decade

Rupa Joshi

35 papers receiving 719 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rupa Joshi India 13 166 162 147 130 116 36 744
Kevin Collins Ireland 16 77 0.5× 603 3.7× 218 1.5× 124 1.0× 20 0.2× 28 1.5k
Ángeles Sánchez-Pérez Australia 13 60 0.4× 400 2.5× 112 0.8× 10 0.1× 38 0.3× 23 921
Tatsuya Fukasawa Japan 18 23 0.1× 717 4.4× 176 1.2× 69 0.5× 61 0.5× 50 1.1k
Edward A. Weinstein United States 14 45 0.3× 557 3.4× 70 0.5× 14 0.1× 48 0.4× 23 1.4k
Sharon L. Ernst United States 14 30 0.2× 464 2.9× 22 0.1× 66 0.5× 49 0.4× 19 860
Claudia Schwarz Germany 14 26 0.2× 338 2.1× 61 0.4× 46 0.4× 142 1.2× 32 1.0k
Sabrina David Italy 23 18 0.1× 1.2k 7.4× 100 0.7× 25 0.2× 52 0.4× 47 1.7k
Tiantian Wang China 16 28 0.2× 400 2.5× 94 0.6× 19 0.1× 24 0.2× 58 1.1k
Aya Yoshimura Japan 18 39 0.2× 334 2.1× 16 0.1× 11 0.1× 69 0.6× 45 848

Countries citing papers authored by Rupa Joshi

Since Specialization
Citations

This map shows the geographic impact of Rupa Joshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rupa Joshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rupa Joshi more than expected).

Fields of papers citing papers by Rupa Joshi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rupa Joshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rupa Joshi. The network helps show where Rupa Joshi may publish in the future.

Co-authorship network of co-authors of Rupa Joshi

This figure shows the co-authorship network connecting the top 25 collaborators of Rupa Joshi. A scholar is included among the top collaborators of Rupa Joshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rupa Joshi. Rupa Joshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Joshi, Rupa, et al.. (2024). SEW2871 reduces seizures via the sphingosine 1‐phosphate receptor‐1 pathway in the pentylenetetrazol and phenobarbitone kindling model of drug‐refractory epilepsy. Clinical and Experimental Pharmacology and Physiology. 51(3). e13839–e13839. 2 indexed citations
2.
Knettel, Brandon A., et al.. (2023). Evaluating the impact of a training program in prehospital trauma care and mental health for traffic police in Arusha, Tanzania. International Emergency Nursing. 70. 101346–101346. 3 indexed citations
3.
4.
Singh, Rahul, Ashutosh Singh, Gladson David Masih, et al.. (2023). A comprehensive insight on the challenges for COVID-19 vaccine: A lesson learnt from other viral vaccines. Heliyon. 9(6). e16813–e16813.
5.
Joshi, Rupa, Abhishek Mishra, Mahendra Kumar, et al.. (2022). A systematic review on SARS-CoV-2 remission: an emerging challenge for its management, treatment, immunization strategies, and post-treatment guidelines. New Microbes and New Infections. 45. 100949–100949. 1 indexed citations
6.
Mishra, Abhishek, et al.. (2022). Epigenetic Interface of Autism Spectrum Disorders (ASDs): Implications of Chromosome 15q11–q13 Segment. ACS Chemical Neuroscience. 13(12). 1684–1696. 8 indexed citations
7.
Mishra, Abhishek, Amit Raj Sharma, Rupa Joshi, et al.. (2022). Granulocyte Colony-Stimulating Factor Improved Core Symptoms of Autism Spectrum Disorder via Modulating Glutamatergic Receptors in the Prefrontal Cortex and Hippocampus of Rat Brains. ACS Chemical Neuroscience. 13(20). 2942–2961. 9 indexed citations
8.
9.
Bansal, Seema, Subodh Kumar, Rupa Joshi, et al.. (2021). Everolimus: A potential therapeutic agent targeting PI3K/Akt pathway in brain insulin system dysfunction and associated neurobehavioral deficits. Fundamental and Clinical Pharmacology. 35(6). 1018–1031. 8 indexed citations
10.
Medhi, Bikash, et al.. (2021). Metformin ameliorates the status epilepticus- induced hippocampal pathology through possible mTOR modulation. Inflammopharmacology. 29(1). 137–151. 15 indexed citations
11.
Bansal, Seema, Subodh Kumar, Amit Raj Sharma, et al.. (2021). Role of protein tyrosine phosphatase 1B inhibitor in central insulin resistance and associated cognitive deficits. Brain Research Bulletin. 171. 113–125. 7 indexed citations
12.
Singh, Ashutosh, Rahul Singh, Phulen Sarma, et al.. (2020). A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV. Virologica Sinica. 35(3). 290–304. 56 indexed citations
13.
Joshi, Rupa, et al.. (2020). A novel approach of targeting refractory epilepsy: Need of an hour. Brain Research Bulletin. 163. 14–20. 13 indexed citations
14.
Joshi, Rupa, Manjari Tripathi, Pooja Gupta, Sheffali Gulati, & Yogendra Kumar Gupta. (2017). Adverse effects & drug load of antiepileptic drugs in patients with epilepsy. The Indian Journal of Medical Research. 145(3). 317–326. 36 indexed citations
15.
Dash, Deepa, Vikas Aggarwal, Rupa Joshi, M.V. Padma, & Manjari Tripathi. (2015). Effect of reduction of antiepileptic drugs in patients with drug-refractory epilepsy. Seizure. 27. 25–29. 30 indexed citations
16.
Joshi, Rupa, et al.. (2015). Pharmacodynamic and pharmacokinetic interaction of Panchagavya Ghrita with phenytoin and carbamazepine in maximal electroshock induced seizures in rats. AYU (An International Quarterly Journal of Research in Ayurveda). 36(2). 196–196. 13 indexed citations
17.
Joshi, Rupa, Manjari Tripathi, Pooja Gupta, & Yogendra Kumar Gupta. (2014). Effect of clobazam as add-on antiepileptic drug in patients with epilepsy. SHILAP Revista de lepidopterología. 12 indexed citations
18.
Joshi, Rupa, Manjari Tripathi, Pooja Gupta, & Yogendra Kumar Gupta. (2014). Effect of clobazam as add-on antiepileptic drug in patients with epilepsy.. PubMed. 140(2). 209–15. 9 indexed citations
19.
Patyar, Sazal, et al.. (2010). Bacteria in cancer therapy: a novel experimental strategy. Journal of Biomedical Science. 17(1). 21–21. 254 indexed citations
20.
Mittal, Niti, Rupa Joshi, Debasish Hota, & Amitava Chakrabarti. (2008). Evaluation of antihyperalgesic effect of curcumin on formalin‐induced orofacial pain in rat. Phytotherapy Research. 23(4). 507–512. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kevin Collins Breakdown of academic impact, for papers by Ángeles Sánchez-Pérez Breakdown of academic impact, for papers by Tatsuya Fukasawa Breakdown of academic impact, for papers by Edward A. Weinstein Breakdown of academic impact, for papers by Sharon L. Ernst Breakdown of academic impact, for papers by Claudia Schwarz Breakdown of academic impact, for papers by Sabrina David Breakdown of academic impact, for papers by Tiantian Wang Breakdown of academic impact, for papers by Aya Yoshimura
Rankless by CCL
2026